S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 94.9 TWD -1.15% Market Closed
Market Cap: 11.3B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCI Pharmtech Inc
Total Receivables Peer Comparison

Comparables:
Y
3705
4746
1789
1795
1720

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Total Receivables
NT$368.8m
CAGR 3-Years
-18%
CAGR 5-Years
-4%
CAGR 10-Years
6%
Y
YungShin Global Holding Corp
TWSE:3705
Total Receivables
NT$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-2%
CAGR 10-Years
1%
Formosa Laboratories Inc
TWSE:4746
Total Receivables
NT$1.2B
CAGR 3-Years
20%
CAGR 5-Years
9%
CAGR 10-Years
4%
ScinoPharm Taiwan Ltd
TWSE:1789
Total Receivables
NT$494.2m
CAGR 3-Years
5%
CAGR 5-Years
-1%
CAGR 10-Years
-7%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Total Receivables
NT$6.4B
CAGR 3-Years
16%
CAGR 5-Years
27%
CAGR 10-Years
21%
Standard Chem & Pharm Co Ltd
TWSE:1720
Total Receivables
NT$1.7B
CAGR 3-Years
15%
CAGR 5-Years
11%
CAGR 10-Years
7%

See Also

What is SCI Pharmtech Inc's Total Receivables?
Total Receivables
368.8m TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Total Receivables amounts to 368.8m TWD.

What is SCI Pharmtech Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
6%

Over the last year, the Total Receivables growth was 28%. The average annual Total Receivables growth rates for SCI Pharmtech Inc have been -18% over the past three years , -4% over the past five years , and 6% over the past ten years .

Back to Top